Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00804427 · ClinicalTrials.gov registry record · NA

Effect of Fish Oil on Plasma Triglycerides in Adults

A NA study, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT00804427: Completed NA study, sponsored by Stanford University.

NCT00804427 is a NA study that has completed, run by Stanford University. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00804427, a NA study, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

The purpose of this small, short pilot study is to determine the feasibility (e.g., recruitment, dose acceptance, retention) of a future longer trial comparing the effects of two types of omega-3 fats from fish oil on plasma triglycerides. The two types of fish oil are composed of (1) omega-3 fatty acids in triglyceride form; and (2) as esterified free fatty acids (i.e. ethyl esters). Although these two types of fish oil supplements are available to the public, it remains unclear whether they are equally effective in lowering plasma triglycerides.

Interventions

  • DIETARY_SUPPLEMENT Fish oil (90% triglycerides)
  • DIETARY_SUPPLEMENT Fish oil (60% triglycerides)
  • DIETARY_SUPPLEMENT Fish oil (ethyl esters)
  • DIETARY_SUPPLEMENT Soy oil

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2008-12
Est. Completion 2010-04
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT00804427

The ClinicalTrials.gov registry entry for NCT00804427 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Fish oil (90% triglycerides) is the first listed.

NCT00804427 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00804427 about?

NCT00804427 is a clinical study titled "Effect of Fish Oil on Plasma Triglycerides in Adults". The purpose of this small, short pilot study is to determine the feasibility (e.g., recruitment, dose acceptance, retention) of a future longer trial comparing the effects of two types of omega-3 fats from fish oil on plasma triglycerides. The two types of fish oil are composed of (1) omega-3 fatty ...

What is the current status of trial NCT00804427?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2008-12. Estimated completion is 2010-04.

What interventions are being tested in trial NCT00804427?

The interventions under investigation include: Fish oil (90% triglycerides) (DIETARY_SUPPLEMENT), Fish oil (60% triglycerides) (DIETARY_SUPPLEMENT), Fish oil (ethyl esters) (DIETARY_SUPPLEMENT), Soy oil (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT00804427?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.